Skip to main content
Equibles

Rathbones Group PLC

Position in MESO — Mesoblast Ltd

CIK 1351991 Liverpool, X0
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$189,650
-$25,931 QoQ
Shares Held
14,017
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 72 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rathbones Group PLC holds $10,663,603 across 18 Biotechnology names. MESO ranks #12 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 23,500 $1,916,895
2 IBRX
ImmunityBio, Inc.
 163,220 $1,428,991
3 XENE
Xenon Pharmaceuticals Inc.
 23,166 $1,398,299
4 ORMP
Oramed Pharmaceuticals Inc.
 233,018 $1,120,816
5 DFTX
Definium Therapeutics, Inc.
 22,800 $1,072,512
6 CORT
Corcept Therapeutics Inc
 11,790 $1,025,140
7 MRNA
Moderna, Inc.
 9,474 $663,464
8 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,044 $518,586

All Filings in MESO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $189,650 14,017
2026-03-31 $215,581 14,017
2025-12-31 $252,866 14,017
2025-09-30 $225,813 14,017
2025-06-30 $152,645 14,017
2025-03-31 $174,932 14,017
2024-12-31 $277,536 14,017
2024-09-30 $114,518 14,017
2024-06-30 $95,455 14,017
2023-12-31 $26,878 24,435
2023-09-30 $30,055 24,435
2023-06-30 $95,540 24,435
2023-03-31 $80,391 24,435
2022-12-31 $71,105 24,435
2022-09-30 $62,309 24,435
2022-06-30 $54,245 24,435
2022-03-31 $103,115 24,435
2021-12-31 $117,288 24,435
2021-09-30 $146,854 24,435
2021-06-30 $182,773 24,435
2021-03-31 $202,077 24,435